FIELD: biotechnology.
SUBSTANCE: isolated antibody or a functional part thereof, capable of specifically binding the respiratory syncytial virus (RSV), is proposed. A nucleic acid molecule encoding the antibody is also provided. An expression vector and isolated cells comprising the said nucleic acid molecule for production of said antibody are described. In addition, the invention relates to a method for production of the said antibody, as well as to application of the said antibody in methods for RSV-related disorder treatment or prevention.
EFFECT: invention allows to effectively bind RSV and can be used for RSV-related disorders therapy.
27 cl, 16 dwg, 2 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RSV-SPECIFIC BINDING MOLECULES AND MEANS FOR OBTAINING THEM | 2008 |
|
RU2527067C2 |
| MEANS AND METHODS FOR OBTAINING HIGH-AFFINITY ANTIBODIES | 2011 |
|
RU2585153C2 |
| MOLECULE SPECIFICALLY BINDING TO RSV | 2009 |
|
RU2540020C2 |
| RSV-SPECIFIC ANTIBODIES AND THEIR FUNCTIONAL PARTS | 2015 |
|
RU2785598C2 |
| METHOD FOR PRODUCING POLYPLOIDIZED MEGAKARYOCYTE AND PLATELETS | 2012 |
|
RU2606764C2 |
| ANTIBODIES BOUND TO EXTRACELLULAR DOMAIN OF TYROSINE KINASE RECEPTOR (ALK) | 2007 |
|
RU2460540C2 |
| NEW ANTIBODY TO CXCR4 AND ITS APPLICATION FOR CANCER DETECTION AND DIAGNOSTICS | 2012 |
|
RU2636345C2 |
| ANTIBODY IGG WITH AFFINITY BINDING WITH RESPECT TO ANTIGENIC COMPLEX CD3, RECOMBINANT NUCLEIC ACIDS ENCODING ANTIBODY LIGHT AND HEAVY CHAIN, METHOD FOR PREPARING SYSTEM, METHOD FOR PREPARING ANTIBODY, METHOD FOR TREATMENT OF PATIENT | 1999 |
|
RU2244720C2 |
| NEW COMPLETELY HUMAN VAP-1 MONOCLONAL ANTIBODIES | 2008 |
|
RU2459832C2 |
| POLYPEPTIDES FOR BONDING WITH "RECEPTOR OF ADVANCED GLYCATION ENDPRODUCTS", THEIR COMPOSITIONS AND METHODS, WHICH THEY TAKE PART IN | 2010 |
|
RU2558301C2 |
